Label: CELLADIX SKIN BALANCING PH 5.5 TONER MIST- niacinamide, adenosine spray
- NDC Code(s): 83490-603-01
- Packager: 2359 US INC
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: unapproved drug other
DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Drug Label Information
Updated March 9, 2023
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active Ingredients
- Purposes
- Uses
- Warnings
- Warnings
- Warnings
- Warnings
- Warnings
- Directions
-
Inactive Ingredients
Water, Diglycerin, Propanediol, Methylpropanediol, Glycerin, Niacinamide, 1,2-Hexanediol, Polyglyceryl-10 Laurate, Sodium Citrate, Butylene Glycol, Dipotassium Glycyrrhizate, Ethylhexylglycerin, Adenosine, Citric Acid, Disodium EDTA, Citrus Aurantium Bergamia (Bergamot) Fruit Oil, Citrus Aurantium Dulcis (Orange) Peel Oil, Eucalyptus Globulus Leaf Extract, Coriandrum Sativum (Coriander) Extract, Laurus Nobilis Leaf Extract, Cinnamomum Cassia Bark Extract, Machilus Thunbergii Branch Extract, Caprylic/Capric Triglyceride, Lavandula Hybrida Oil, Phosphatidylcholine, Polyglutamic Acid, Lavandula Angustifolia (Lavender) Oil, Ceramide NP, Sodium Hyaluronate, Pentylene Glycol, Laminaria Japonica Extract, Ulmus Davidiana Root Extract, Viola Mandshurica Flower Extract, Dioscorea Japonica Root Extract, Aloe Barbadensis Leaf Extract, Caprylyl Glycol, Hydrogenated Lecithin, Hydroxypropyltrimonium Hyaluronate, Glycine, Phytosterols, Serine, Glutamic Acid, Alanine, Lysine, Hydrolyzed Hyaluronic Acid, Sodium Acetylated Hyaluronate, Proline, Arginine, Threonine, Palmitic Acid, Stearic Acid, Sodium Hyaluronate Crosspolymer, Hydrolyzed Sodium Hyaluronate., Hyaluronic Acid, Potassium Hyaluronate, Myristic Acid
- Label
-
INGREDIENTS AND APPEARANCE
CELLADIX SKIN BALANCING PH 5.5 TONER MIST
niacinamide, adenosine sprayProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:83490-603 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) NIACINAMIDE 2 g in 100 mL ADENOSINE (UNII: K72T3FS567) (ADENOSINE - UNII:K72T3FS567) ADENOSINE 0.04 g in 100 mL Inactive Ingredients Ingredient Name Strength LAVANDIN OIL (UNII: 9RES347CKG) GLUTAMIC ACID (UNII: 3KX376GY7L) LYSINE (UNII: K3Z4F929H6) ARGININE (UNII: 94ZLA3W45F) HYALURONIC ACID (UNII: S270N0TRQY) MYRISTIC ACID (UNII: 0I3V7S25AW) POLYGLYCERYL-10 LAURATE (UNII: MPJ2Q8WI8G) CHINESE CINNAMON (UNII: WS4CQ062KM) DIGLYCERIN (UNII: 3YC120743U) GLYCERIN (UNII: PDC6A3C0OX) 1,2-HEXANEDIOL (UNII: TR046Y3K1G) SODIUM CITRATE (UNII: 1Q73Q2JULR) DIOSCOREA JAPONICA ROOT (UNII: I43FCF3356) CAPRYLYL GLYCOL (UNII: 00YIU5438U) GLYCINE (UNII: TE7660XO1C) SERINE (UNII: 452VLY9402) ETHYLHEXYLGLYCERIN (UNII: 147D247K3P) CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) SODIUM ACETYLATED HYALURONATE (UNII: WN66R7GL93) BUTYLENE GLYCOL (UNII: 3XUS85K0RA) BAY LEAF (UNII: WS0Y3M85RF) PROPANEDIOL (UNII: 5965N8W85T) GLYCYRRHIZINATE DIPOTASSIUM (UNII: CA2Y0FE3FX) EDETATE DISODIUM ANHYDROUS (UNII: 8NLQ36F6MM) ORANGE OIL (UNII: AKN3KSD11B) CORIANDRUM SATIVUM WHOLE (UNII: 740M8BF6EF) MACHILUS THUNBERGII BRANCH (UNII: 301F5K1I0R) ALANINE (UNII: OF5P57N2ZX) PROLINE (UNII: 9DLQ4CIU6V) CERAMIDE NP (UNII: 4370DF050B) HYALURONATE SODIUM (UNII: YSE9PPT4TH) PENTYLENE GLYCOL (UNII: 50C1307PZG) ULMUS DAVIDIANA ROOT (UNII: URQ79U8261) VIOLA MANDSHURICA FLOWER (UNII: 46MR945M6X) WATER (UNII: 059QF0KO0R) LAMINARIA JAPONICA (UNII: WE98HW412B) ALOE VERA LEAF (UNII: ZY81Z83H0X) STEARIC ACID (UNII: 4ELV7Z65AP) METHYLPROPANEDIOL (UNII: N8F53B3R4R) LAVENDER OIL (UNII: ZBP1YXW0H8) THREONINE (UNII: 2ZD004190S) BERGAMOT OIL (UNII: 39W1PKE3JI) EUCALYPTUS GLOBULUS LEAF (UNII: S546YLW6E6) MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U) PALMITIC ACID (UNII: 2V16EO95H1) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:83490-603-01 120 mL in 1 BOTTLE, SPRAY; Type 0: Not a Combination Product 05/24/2023 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 05/24/2023 Labeler - 2359 US INC (118974080) Registrant - 2359 US INC (118974080) Establishment Name Address ID/FEI Business Operations isamogu Inc. 695695834 manufacture(83490-603)
